{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:01:38Z","timestamp":1781139698286,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-026-07811-9","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T15:26:17Z","timestamp":1775921177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Positive correlation between IL-6 levels and lumbar bone mineral density in menopausal women diagnosed with osteoporosis in comparison to menopausal women without osteoporosis"],"prefix":"10.1186","volume":"19","author":[{"given":"Reza","family":"Alhosseini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Aghaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Ghorbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safoura","family":"Khajeniazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"issue":"4","key":"7811_CR1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s11914-009-0023-2","volume":"7","author":"RR McLean","year":"2009","unstructured":"McLean RR. Proinflammatory cytokines and osteoporosis. Curr Osteoporos Rep. 2009;7(4):134\u20139.","journal-title":"Curr Osteoporos Rep"},{"key":"7811_CR2","first-page":"1","volume":"16","author":"N Salari","year":"2021","unstructured":"Salari N, Ghasemi H, Mohammadi L, Behzadi MH, Rabieenia E, Shohaimi S, Mohammadi M. The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. 2021;16:1\u201320.","journal-title":"J Orthop Surg Res"},{"key":"7811_CR3","first-page":"117954412110724","volume":"15","author":"T Eghbali","year":"2022","unstructured":"Eghbali T, Abdi K, Nazari M, Mohammadnejad E, Gheshlagh RG. Prevalence of osteoporosis among Iranian postmenopausal women: a systematic review and Meta-analysis. Clin Med Insights. 2022;15:11795441211072471.","journal-title":"Clin Med Insights: Arthritis Musculoskelet Disorders"},{"issue":"1","key":"7811_CR4","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.37506\/v11\/i1\/2020\/ijphrd\/194029","volume":"11","author":"Correlation of Interleukin-6 with Serum Estradiol Mean Levels in Menopause Women at Rsup H Adam Malik Medan","year":"2020","unstructured":"N Latjindung, MF Ganis Siregar, H Hartono, SN Lumbanraja, D Edianto, IH Effendi. Correlation of interleukin-6 with serum estradiol mean levels in menopause women at Rsup H Adam Malik Medan. Indian J Public Health Res Dev. 2020;11(1):1337\u201342.","journal-title":"Indian J Public Health Res Dev"},{"key":"7811_CR5","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3389\/fendo.2018.00788","volume":"9","author":"D Harmer","year":"2018","unstructured":"Harmer D, Falank C, Reagan MR. Interleukin-6 interweaves the bone marrow microenvironment, bone loss, and multiple myeloma. Front Endocrinol. 2018;9:788.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"7811_CR6","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1210\/jcem.87.4.8397","volume":"87","author":"S Khosla","year":"2002","unstructured":"Khosla S, Atkinson EJ, Dunstan CR, O\u2019Fallon WM. Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. J Clin Endocrinol Metab. 2002;87(4):1550\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"7811_CR7","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3389\/fendo.2018.00788","volume":"9","author":"D Harmer","year":"2019","unstructured":"Harmer D, C.a.R F. Interleukin-6 interweaves the bone marrow microenvironment, bone loss, and multiple myeloma. Front Endocrinol. 2019;9:788.","journal-title":"Front Endocrinol"},{"issue":"5066","key":"7811_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.1621100","volume":"257","author":"RL Jilka","year":"1992","unstructured":"Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 1992;257(5066):88\u201391.","journal-title":"Science"},{"key":"7811_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcdb.2021.05.014","volume":"123","author":"V Fischer","year":"2022","unstructured":"Fischer V, Haffner-Luntzer M. Interaction between bone and immune cells: Implications for postmenopausal osteoporosis. Semin Cell Dev Biol. 2022;123:14\u201321.","journal-title":"Semin Cell Dev Biol"},{"key":"7811_CR10","doi-asserted-by":"crossref","unstructured":"Wang TH, Chengqi TNF-\u03b1. and IL-6: the link between immune and bone system Curr Drug Targets. 2020. 21(3): 213\u201327.","DOI":"10.2174\/18735592MTAwhMzkdy"},{"issue":"1","key":"7811_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S8756-3282(99)00243-4","volume":"26","author":"KM Chiu","year":"2000","unstructured":"Chiu KM, Arnaud CD, Ju J, Mayes D, Bacchetti P, Weitz S, Keller ET. Correlation of estradiol, parathyroid hormone, interleukin-6, and soluble interleukin-6 receptor during the normal menstrual cycle. Bone. 2000;26(1):79\u201385.","journal-title":"Bone"},{"issue":"10","key":"7811_CR12","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/jbmr.5650081003","volume":"8","author":"EM Greenfield","year":"1993","unstructured":"Greenfield EM, Gornik SA, Horowitz MC, Donahue HJ, Shaw SM. Regulation of cytokine expression in osteoblasts by parathyroid hormone: rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA. J Bone Min Res. 1993;8(10):1163\u201371.","journal-title":"J Bone Min Res"},{"issue":"6","key":"7811_CR13","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/jbmr.5650110606","volume":"11","author":"JH Pollock","year":"1996","unstructured":"Pollock JH, Blaha MJ, Lavish SA, Stevenson S, Greenfield EM. In vivo demonstration that parathyroid hormone and parathyroid hormone-related protein stimulate expression by osteoblasts of interleukin-6 and leukemia inhibitory factor. J Bone Min Res. 1996;11(6):754\u20139.","journal-title":"J Bone Min Res"},{"key":"7811_CR14","doi-asserted-by":"crossref","unstructured":"Pilbeam C. Prostaglandins and bone. Bone regulators and osteoporosis therapy, 2020. 157\u2013175.","DOI":"10.1007\/164_2019_332"},{"issue":"1","key":"7811_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/art.21537","volume":"54","author":"PK Wong","year":"2006","unstructured":"Wong PK, Quinn JM, Sims NA, van Nieuwenhuijze A, Campbell IK, Wicks IP. Interleukin-6 modulates production of T lymphocyte\u2013derived cytokines in antigen\u2010induced arthritis and drives inflammation\u2010induced osteoclastogenesis. Arthr Rheumatism. 2006;54(1):158\u201368.","journal-title":"Arthritis Rheumatism: Official J Am Coll Rheumatol"},{"issue":"3","key":"7811_CR16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1359\/jbmr.1998.13.3.393","volume":"13","author":"RD Devlin","year":"1998","unstructured":"Devlin RD, Reddy SV, Savino R, Ciliberto G, Roodman GD. IL-6 mediates the effects of IL\u20101 or TNF, but not PTHrP or 1, 25 (OH) 2D3, on osteoclast\u2010like cell formation in normal human bone marrow cultures. J Bone Miner Res. 1998;13(3):393\u20139.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"7811_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.joen.2019.12.001","volume":"46","author":"CCB Meneses","year":"2020","unstructured":"Meneses CCB, Pizzatto LN, Andrade FFF, Sipert CR. Prostaglandin E2 affects interleukin 6 and monocyte chemoattractant protein 1\/CCL2 production by cultured stem cells of apical papilla. J Endod. 2020;46(3):413\u20138.","journal-title":"J Endod"},{"key":"7811_CR18","doi-asserted-by":"publisher","first-page":"155655","DOI":"10.1016\/j.cyto.2021.155655","volume":"146","author":"NA Sims","year":"2021","unstructured":"Sims NA. Influences of the IL-6 cytokine family on bone structure and function. Cytokine. 2021;146:155655.","journal-title":"Cytokine"},{"key":"7811_CR19","doi-asserted-by":"crossref","unstructured":"Yasovanthi Jeedigunta SS, Rajender Rao Kalashikam R Manchala., Inflammation S. A risk factor for osteoporosis in pre- and post-menopausal women. J Women\u2019s Health Dev. 2020. 3(4): 423\u2013431.","DOI":"10.26502\/fjwhd.2644-28840050"},{"issue":"5","key":"7811_CR20","first-page":"2032","volume":"86","author":"C Scheidt-Nave","year":"2001","unstructured":"Scheidt-Nave C, Leidig-Bruckner HBG, et al. Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab. 2001;86(5):2032\u201342.","journal-title":"J Clin Endocrinol Metab"},{"key":"7811_CR21","doi-asserted-by":"crossref","unstructured":"Li X, Zhang ZZ, Yang Y. H., IL-6 Contributes to the defective osteogenesis of bone marrow stromal cells from the vertebral body of the glucocorticoid-induced osteoporotic mouse. PLoS ONE, 2016. 11: e0154677","DOI":"10.1371\/journal.pone.0154677"},{"key":"7811_CR22","doi-asserted-by":"crossref","unstructured":"Latjindung N, Hartono GSM, Lumbanraja H, Edianto H, Effendi D. I., Correlation of Interleukin-6 with Serum Estradiol Mean Levels in Menopause Women at Rsup H Adam Malik Medan. Indian J Public Health Res Dev, 2020. 11(1).","DOI":"10.37506\/v11\/i1\/2020\/ijphrd\/194029"},{"key":"7811_CR23","doi-asserted-by":"crossref","unstructured":"Wang X, Qi ZY, Sun B, Sun K, Liu C, Fang N, Wei S, Xie X Yand, Zhu L. IL-6 and Leptin are potential biomarkers for osteoporotic fracture risk assessment and prediction of postmenopausal women with low bone mass: a follow-up study using a regional sample cohort. Oxidative Med Cell Longev; 2022. pp. 1\u201310.","DOI":"10.1155\/2022\/8691830"},{"key":"7811_CR24","doi-asserted-by":"crossref","unstructured":"Ilesanmi-Oyelere B, Kuhn-Sherlock SL, McConnell B, Mros M. S, and R.N.a.C.K.M.I.-O.e.a. Coad J, Inflammatory markers and bone health in postmenopausal women: a cross-sectional overview. Immun Ageing 2019. 16: 15.","DOI":"10.1186\/s12979-019-0155-x"},{"key":"7811_CR25","first-page":"65","volume":"7","author":"W Farhan Jabber","year":"2015","unstructured":"Farhan Jabber W, Gorial ZT, Al-Naaimi F. Salivary Interleukin 6 is a valid biomarker for diagnosis of osteoporosis in postmenopausal women. Chem Mater Res. 2015;7:65\u20139.","journal-title":"Chem Mater Res"},{"key":"7811_CR26","doi-asserted-by":"crossref","unstructured":"Baptista Menezes A, Gon\u00e7alves DOP, Oliveira HI. Are cytokines (IL-6, CRP and adiponectin) associated with bone mineral density in a young adult birth cohort? BMC Musculoskelet Disord, 2018. 19: 427","DOI":"10.1186\/s12891-018-2357-3"},{"key":"7811_CR27","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11357-011-9244-2","volume":"34","author":"O Kim","year":"2012","unstructured":"Kim O, Paik CJ, Seo J, Jang H Y&, Cavaillon J, Lee J. Effects of aging and menopause on serum interleukin-6 levels and peripheral blood mononuclear cell cytokine production in healthy nonobese women. AGE. 2012;34:415\u201325.","journal-title":"AGE"},{"key":"7811_CR28","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/jcem.87.6.8577","volume":"87","author":"U Masiukiewicz","year":"2015","unstructured":"Masiukiewicz U, Gulanski MM. Evidence that the IL-6\/IL-6 Soluble receptor cytokine system plays a role in the increased skeletal sensitivity to PTH in estrogen-deficient women. J Clin Endocrinol Metabolism. 2015;87:2892\u20138.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"7811_CR29","doi-asserted-by":"crossref","unstructured":"Charles A, O\u2019Brien RLJ, Fu Q, Stewart S, Weinstein RS, Stavros C, Manolagas. IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice. Am J Physiol Endocrinol Metab, 2005. 289: E784\u201393.","DOI":"10.1152\/ajpendo.00029.2005"},{"key":"7811_CR30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1365-2249.2004.02419.x","volume":"136","author":"A Safley","year":"2004","unstructured":"Safley A, Villinger F, Jackson EH, Tucker-Buden, Cohen C. Weber C. J.Interleukin-6 production and secretion by human parathyroids. Clin Exp Immunol. 2004;136:145\u201356.","journal-title":"Clin Exp Immunol"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-026-07811-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-026-07811-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-026-07811-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:30:53Z","timestamp":1781137853000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13104-026-07811-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7811"],"URL":"https:\/\/doi.org\/10.1186\/s13104-026-07811-9","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent was obtained from all participants included in the study, and the consent was informed to all participants. This study was approved by the Deputy of Research, Golestan University of Medical Sciences. Ethics Committee (reference number IR.GOUMS.REC.1402.120).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"250"}}